He bu QIAN, Guijuan ZOU, Chao LI, Qi Fang HE, Jun LIU

Bone marrow mesenchymal stem cells attenuate LPS-induced acute lung injury in mice by promoting RvE1/ProD1 and modulating Treg/Th17 balance

Acute lung injury (ALI) and its severe form acute respiratory distress syndrome (ARDS) are respiratory failures caused by excessive alveolar inflammation with high mortality. In this study, we investigated the effects of bone marrow mesenchymal stem cells (BMSCs) on lung injury of lipopolysaccharide (LPS)-induced ALI and explored the associated mechanisms. BMSCs were isolated, cultured, identified by staining with CD34 and CD44 surface markers. LPS-induced ALI mouse model was generated by injecting with LPS and divided into ALI group and ALI+BMSCs group. Mice treated without any reagents were assigned as Control, mice transplanted with BMSCs were assigned as BMSCs group. Regulatory T (Treg) and Th17 percentages were evaluated using flow cytometry. Proresolving mediators (resolvin E1 (RvE1), protectin D1 (ProD1)) in lung tissue and cytokines (interleukin-6 (IL-6) and IL-17) in serum were analyzed by ELISA. Myeloperoxidase (MPO) activity was determined. Cultured cells demonstrated typical characteristics of BMSCs. BMSCs transplantation (ALI+BMSCs) obviously alleviated LPS-induced ALI in mice. BMSCs transplantation significantly decreased MPO activity in LPS-induced ALI in mice compared to the Control group (p < 0.05). BMSCs transplantation markedly increased Treg percentages and decreased dendritic cells (DCs) and Th17 cells percentages compared to those of the Control group (p < 0.05). BMSCs transplantation remarkably enhanced RvE1 and ProD1 levels in LPS-induced ALI (ALI+BMSCs) compared to the ALI group (p < 0.05). BMSCs transplantation significantly attenuated IL-6 and IL-17 levels in serum of mice treated with LPS (ALI+BMSCs) compared to those of the ALI group (p < 0.05). In conclusion, BMSCs transplantation effectively attenuated LPS-induced pathological injury of ALI in mice, at least partly through promoting proresolving mediators RvE1 and ProD1 and modulating the balance of Treg/Th17.

PDF

___

Adamzik M, Broll J, Steinmann J, Westendorf AM, Rehfeld I et al. (2013). An increased alveolar CD4+ CD25+ Foxp3+ T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality. Intensive Care Medicine 39 (10): 1743-51. doi: 10.1007/s00134-013-3036-3
Chen D, Tang P, Liu L, Wang F, Xing H et al. (2018). Bone marrowderived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway. Cell Cycle 17 (7): 858-867. doi: 10.1080/15384101.2018.1442624
Chen QH, Wu F, Liu L, Chen HB, Zheng RQ et al. (2020). Mesenchymal stem cells regulate the Th17/Treg cell balance partly through hepatocyte growth factor in vitro. Stem Cell Research and Therapy 11 (1): 91. doi: 10.1186/s13287-020- 01612-y
Chiurchiù V, Leuti A, Dalli J, Jacobsson A, Battistini L et al. (2016). Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Science Translational Medicine 8 (353): 353ra111. doi: 10.1126/ scitranslmed.aaf7483
D’Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH et al. (2009). CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. Journal of Clinical Investigation 119 (10): 2898-913. doi: 10.1172/JCI36498
Dong L, He HL, Lu XM, Yang Y, Qiu HB (2012). Modulation of FLT3 signaling targets conventional dendritic cells to attenuate acute lung injury. APMIS 120 (10): 808-818. doi: 10.1111/j.1600- 0463.2012.02906.x
Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G et al. (2006). Resolvin D series and protectin D1 mitigate acute kidney injury. Journal of Immunology 177 (9): 5902-5911. doi: 10.4049/jimmunol.177.9.5902
Englert JA, Bobba C, Baron RM (2019). Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome. JCI Insight 4 (2): e124061. doi: 10.1172/jci.insight.124061
Fredman G (2019). DELineating resolution of inflammation. Nature Immunology 20 (1): 2-3. doi: 10.1038/s41590-018-0278-9
Fullerton JN, Gilroy DW (2016). Resolution of inflammation: a new therapeutic frontier. Nature Reviews Drug Discovery 15 (8): 551-567. doi: 10.1038/nrd.2016.39
Gagliani N, Amezcua Vesely MC, Iseppon A, Brockmann L, Xu H et al. (2015). Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523 (7559): 221- 225. doi: 10.1038/nature14452
Islam D, Huang Y, Fanelli V, Delsedime L, Wu S et al. (2019). Identification and modulation of microenvironment is crucial for effective MSC therapy in acute lung injury. American Journal of Respiratory and Critical Care Medicine 199 (10): 1214-1224. doi: 10.1164/rccm.201802-0356OC
Leslie M (2015). Inflammation’s stop signals. Science 347 (6217): 18- 21. doi: 10.1126/science.347.6217.18
Levy BD, Serhan CN (2014). Resolution of acute inflammation in the lung. Annul Review of Physiology 76 (1): 467-492. doi: 0.1146/ annurev-physiol-021113-170408
Liu J, Zhang PS, Yu Q, Liu L, Yang Y et al. (2012b). Kinetic and distinct distribution of conventional dendritic cells in the early phase of lipopolysaccharide-induced acute lung injury. Molecular and Biology Report 39 (12): 10421-10431.
Liu J, Zhang PS, Yu Q, Liu L, Yang Y et al. (2012a). Losartan inhibits conventional dendritic cell maturation and Th1 and Th17 polarization responses: Novel mechanisms of preventive effects on lipopolysaccharide-induced acute lung injury. International Journal of Molecular Medicine 29 (2): 269-276.
Liu L, Yang Y, Gao Z, Li M, Mu X et al. (2018). Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study. Journal of Thoracic Disease 10 (9): 5394-5404. doi: 10.21037/jtd.2018.08.137
Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR et al. (2019). Acute respiratory distress syndrome. Nature Reviews Disease Primers 5 (1): 18. doi: 10.1038/s41572-019- 0069-0
Qin H, Zhao A (2020). Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell 11 (10): 707-722. doi: 10.1007/s13238-020-00738-2
Schwab JM, Chiang N, Arita M, Serhan CN (2007). Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447 (7146): 869-874. doi: 10.1038/nature05877
Serhan CN, Chiang N, Van Dyke TE (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology 8 (5): 349-61. doi: 10.1038/ nri2294
Sharma M, Schlegel MP, Afonso MS, Brown EJ, Rahman K et al. (2020). Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression. Circulation Research 127 (3): 335-353. doi: 10.1161/CIRCRESAHA.119.316461
Verjans E, Ohl K, Yu Y, Lippe R, Schippers A et al. (2013). Overexpression of CREMalpha in T cells aggravates lipopolysaccharide-induced acute lung injury. Journal of Immunology 191 (3): 1316-1323. doi: 10.4049/ jimmunol.1203147
Weaver CT, Hatton RD (2009). Interplay between the Th17 and Treg cell lineages: a (co-)evolutionary perspective. Nature Reviews Immunology 9 (12): 883-9.
Weiskopf D, Schmitz KS, Raadsen MP (2020). Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Science Immunology 5 (48): eabd2071. doi: 10.1038/nri2660
Wei-xu H, Qin X, Zhu W, Yuan-yi C, Li-feng Z et al. (2014). Therapeutic potential of anti-IL-1 beta IgY in guinea pigs with allergic asthma induced by ovalbumin. Molecular Immunology 58 (1): 139-149. doi: 10.1016/j.molimm.2013.11.006
Wei-Xu H, Wen-Yun Z, Xi-Ling Z, Zhu W, Li-Hua W et al. (2016). Anti-Interleukin-1 Beta/Tumor Necrosis Factor-Alpha IgY Antibodies Reduce Pathological Allergic Responses in Guinea Pigs with Allergic Rhinitis. Mediators of Inflammation 2016: 3128182. doi: 10.1155/2016/3128182
Yang H, Tian W, Wang S, Liu X, Wang Z et al. (2018). TSG-6 secreted by bone marrow mesenchymal stem cells attenuates intervertebral disc degeneration by inhibiting the TLR2/NF-kB signaling pathway. Laboratory Investigation 98 (6): 755-772. doi: 10.1038/s41374-018-0036-5
Yu ZX, Ji MS, Yan J, Cai Y, Liu J et al. (2015). The ratio of Th17/ Treg cells as a risk indicator in early acute respiratory distress syndrome. Critical Care 19 (1): 82. doi: 10.1186/s13054-015- 0811-2
Zhang B, Jia H, Liu J, Yang Z, Jiang T et al. (2010). Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4. Journal of Immunology 185 (12): 7199-7206. doi: 10.4049/jimmunol.1001876
Zhang J, Wang M, Ye J, Liu J, Xu Y et al. (2020). The anti-inflammatory mediator resolvin E1 protects mice against lipopolysaccharideinduced heart injury. Frontiers in Pharmacology 11 (1): 203. doi: 10.3389/fphar.2020.00203